language_icon
EN
HI

Curis Lifesciences Share price

CURIS

132

0.00 (0.00%)
Last updated on 13 May, 2026 | 13:32 IST
Today's High

132.00

Today's Low

129.00

52 Week Low

83.60

52 Week High

147.90

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Curis Lifesciences Chart

Curis Lifesciences Share Key Metrics

Volume
2000.00
Market Cap
106.71 CR
LTQ@LTP
1000@132.00
ATP
130.5
Var Margin
53.5 %
Circuit Range
105.6-158.4
Delivery %
88.89 %
Value
2.61 L
ASM/GSM
No
Market Lot
1000

Summary

Curis Lifesciences share price stands at ₹132 at 13 May, 2026 | 13:32. The stock Curis Lifesciences intraday movement has stayed between ₹129.00 and ₹132.00, while on a 52-week basis it has fluctuated from ₹83.60 to ₹147.90.
In terms of trading activity, Curis Lifesciences has recorded a volume of 2000 shares. The Curis Lifesciences has a market cap of ₹8084434. The stock’s Average Traded Price (ATP) stands at ₹13050, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 1000, 13200.
The Curis Lifesciences operates within a circuit range of ₹105.6-158.4 – ₹105.6-158.4, with a Value of ₹2.61 L. The Delivery Percentage for the day is 88.89%. Additionally, Curis Lifesciences currently falls under the No framework, and trades with a market lot size of 1000.

Curis Lifesciences Fundamentals

View More
P/E Ratio

0

P/B Ratio

0

Div. Yield

0

Sector P/E

68.46

Sector P/B

3.54

Sec. Div. Yield

0.57

Curis Lifesciences Resistance and Support

Pivot 130.32

Resistance

First Resistance

133.69

Second Resistance

135.37

Third Resistance

138.74

Support

First Support

128.64

Second Support

125.27

Third Support

123.59

Curis Lifesciences Shareholding Pattern

View More
  • 2026-27
Total Promoters
Segment
Percent

Total Promoters

68.03%

Mutual Fund

0%

Insurance

0%

Foreign Institutional Investors

1.19%

Domestic Institutional Investors

4.35%

Retail

26.43%

Others

0%

Total Promoters
MAR '26
68.03%

Curis Lifesciences Corporate Actions

DateAgenda
2025-12-04Quarterly Results

Curis Lifesciences News

Eris Lifesciences Limited

Eris Lifesciences' subsidiary Eris Therapeutics had its bank loan facilities rated 'IND AA/Stable/IND A1+' by India Ratings. This includes a new assignment for INR 100 crore and affirmation for INR 420 crore, which was reduced from INR 469 crore.
May 12 2026 19:05:00

Eris Lifesciences Limited

India Ratings and Research (Ind-Ra) affirmed Eris Lifesciences's Long-term Issuer Rating and bank facilities at 'IND AA' with a Stable Outlook. This reflects the company's sustained healthy operating performance.
May 08 2026 17:05:00

About Curis Lifesciences

NSE : 759825  
BSE : 0  
ISIN : INE1BZN01016  

Our Company was originally formed and registered as a Partnership Firm under the Partnership Act 1932 (“Partnership Act”) in the name and style of “M/s Loreto Pharmaceutacals” pursuant to a deed of partnership dated June 2 2010. Thereafter " M/s Loreto Pharmaceuticals” was converted from Partnership Firm to a Private Limited Company under the Companies Act 2013 in the name of “Curis Lifesciences Private Limited” and received a certificate of incorporation datedMarch 23 2016 issued by Assistant Registrar of Companies Gujarat. Subsequently our Company was converted into a public limited company and the name of our Company was changed from “Curis Lifesciences Private Limited” to “Curis Lifesciences Limited” vide Special Resolution dated May 6 2024 the status of the Company was changed to public limited and the fresh certificate of incorporation consequent to conversion bearing Corporate Identification Number U24230GJ2016PLC086559 was issued on August 9 2024 by the Assistant Registrar of Companies/ Deputy Registrar of Companies/ Registrar of Companies Central Processing Centre. From year 2010 to 2016 our partnership firm was engaged in the marketing and trading of various pharmaceutical products. As a partnership firm our product portfolio included tablets capsules oral liquids creams ointments injections lotions oral powders and other nutraceuticals products. We procured finished goods from manufacturers and distributed them to various wholesalers and other clients throught the country.MAJOR EVENTS:2011- Started Business by starting a Partnership Firm with two Partners in name of "M/s Loreto Pharmaceutical" by Mr. Dasharathbhai Patel and Mr. Piyush Gordhanbhai Antala.2016- The Partnership Firm got converted into Private Company post conversion and receiving Certificate of Incorporation on March 23rd 2016.2018- The Company received FDA License for manufacturing Pharma products.2019- The Company availed Kenya PPC board approval and approval from Ministry of Health - Republic of Yemen State Good Manufacturing Practices and GLP licence from Local FDA2020- The Company received WHO GMP certificate.2021- The Company received FDA Approval from Philippines during the tragic era of COVID-192022- Renewal of the WHO Certificates and Nigeria NAFDAC Approval2023- Retention of FDA License for manufacturing Pharma products.2025- Conversion From Private Limited into Public Limited company.

Read More

Curis Lifesciences Management

NamePosition
Nikhil PurohitCompany Secretary & Compliance Officer
Dharmesh Dasharathbhai PatelChairman & Managing Director
View More

Curis Lifesciences Similar Stocks

No Data Found

Curis Lifesciences FAQs

The Buying Price of Curis Lifesciences share is 132 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Curis Lifesciences stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Curis Lifesciences, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Curis Lifesciences shares is 0. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Curis Lifesciences shares is 0. Useful to assess the stock's value relative to its book value.

To assess Curis Lifesciences’s valuation compare Sector P/E, P/B which are 68.46 & 3.54 with sector averages, along with growth rates and financial metrics.

The Market Cap of Curis Lifesciences is 106.71 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Curis Lifesciences share price is 147.90 & 83.60. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Curis Lifesciences belongs to the Healthcare sector.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost